<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01726114</url>
  </required_header>
  <id_info>
    <org_study_id>C8CSP_19042012</org_study_id>
    <nct_id>NCT01726114</nct_id>
  </id_info>
  <brief_title>A Clinical Study of the C8 MediSensors Optical Glucose Monitor™</brief_title>
  <acronym>Spectrum</acronym>
  <official_title>A Clinical Study to Evaluate the Performance of the C8 MediSensors Optical Glucose Monitor™ During On-Site Testing and Real Time Use Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>C8 MediSensors, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>C8 MediSensors, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare glucose measurements from the C8 MediSensors
      non-invasive Optical Glucose Monitor™ System to blood glucose measurements from the Yellow
      Springs Instrument(YSI) blood glucose analyzer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, non-randomized, open label study to evaluate the performance of the C8
      MediSensors non-invasive Optical Glucose Monitor™ on individuals with diabetes mellitus.
      Capillary blood samples will be obtained throughout a daily study session; the study session
      may last for up to 12 hours. Blood glucose will be measured on a YSI blood glucose analyzer.
      Subjects may adjust food intake and insulin administration so device performance is evaluated
      across a broad range of glucose concentrations. Glucose measurements will be time matched and
      paired for comparison. Skin effects and adverse events will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Performance of the test device in comparison to the reference device</measure>
    <time_frame>6 months</time_frame>
    <description>The primary objective is to characterize the accuracy of the non-invasive glucose measurements from the Optical Glucose Monitor™ to blood glucose measurements on a sample size of approximately 30 subjects with 1000 time matched, paired data points.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Non-invasive Optical Glucose Monitor™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive Optical Glucose Monitor™</intervention_name>
    <description>Test device</description>
    <arm_group_label>Non-invasive Optical Glucose Monitor™</arm_group_label>
    <other_name>Continuous glucose monitor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>YSI blood glucose analyzer</intervention_name>
    <description>Reference device</description>
    <arm_group_label>Non-invasive Optical Glucose Monitor™</arm_group_label>
    <other_name>Yellow Springs Instruments (YSI) blod glucose analyzer</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years of age or older.

          2. Understands and agrees to comply with study instructions.

          3. Read, understood, signed and dated the Informed Consent Form.

        Exclusion Criteria:

          1. Pregnancy.

          2. Extensive skin changes or diseases that preclude wearing the test device at the
             proposed wear site(s) (e.g., extensive psoriasis, recent burns or severe sunburn,
             extensive eczema, extensive scarring, extensive tattoos, dermatitis herpetiformis).

          3. Employed by a company within the diabetes field other than the study sponsor.

          4. Medical history or any condition that may, in the opinion of the investigator,
             compromise the subject's ability to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vice President, Clincal, Regulatory, Quality</last_name>
    <role>Principal Investigator</role>
    <affiliation>C8 MediSensors, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>C8 MediSensors, Inc.</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2012</study_first_submitted>
  <study_first_submitted_qc>November 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2012</study_first_posted>
  <last_update_submitted>March 23, 2013</last_update_submitted>
  <last_update_submitted_qc>March 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>continuous Glucose Monitor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

